REGENPRP
DEAD

Serial Number

86984684

Owner

REGEN LAB SA

Attorney

Lindsay Kaplan

First Use Date

Jul 28, 2025

Filing Date

Sep 18, 2015

Add to watchlist:

No watchlists yet
View on USPTO

REGENPRP Trademark

Serial Number: 86984684

REGENPRP is a trademark filed by REGEN LAB SA on September 18, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

REGEN LAB SA (31 trademarks)

En Budron B2

Entity Type: 99

REGENLAB USA LLC

95 Greene Street
Jersey City, NJ 07302

Entity Type: 16

Trademark Details

Filing Date

September 18, 2015

Registration Date

Not Registered

First Use Anywhere

July 28, 2025

First Use in Commerce

July 28, 2025

Published for Opposition

May 23, 2023

Goods & Services

pharmaceutical and veterinary preparations, namely, solutions for application on and under tissue, bone and organ for the purpose of promoting cellular regeneration, tissue adhesion, wound healing, bone or periodontum growth and bone, organ or tissue regeneration; sanitary preparations for medical purposes; adjuvants for medical purposes; biological preparations for medical purposes for the treatment of osteoarthritis, arthropathy, tendinopathy, bone nonunion, osteonecrosis, femoral fracture, tendon rupture, osteochondral lesions, carpal tunnel, neuralgia, spinal fusion surgery, lumbar spine surgery, paraspinal surgery, alopecia, scar revision, fine lines and wrinkles, melasma, facial reconstruction wound healing, ulcers, chronic skin diseases, tendon exposure and injuries, burns, Lichen sclerosis, vaginal mesh exposure, dyspareunia, ovarian regeneration, folliculogenesis activation, peyronie's disease, Tooth avulsion, maxillary or mandibular defects, tympanic perforation, cochlear implant surgery, Macular degeneration, dry eye syndrome, wound care; pharmaceutical skin lotions; tissues impregnated with pharmaceutical lotions; medical dressings; surgical cloth tissues; medicated skin care preparations; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; preparations for medical purposes for cleaning the skin; solution kits for reconstituting allograft tissue; cells for medical or clinical purposes; all-purpose disinfectants; disinfectants for hygiene purposes; kits containing chemical reagents used for medical diagnosis; plant extracts, and human and animal tissue and cells in the nature of cultures, grafts and fresh cells, for medical and veterinary use

medical devices, namely, kits comprising medical syringes, tubes, medical tubes, vials, jars, bags, pouches, cartridges, bottles, cylinders or pods, needles, holders, gels, connectors, tourniquets, plaster, pads, masks, pliers, creams, spatulas, flasks, discs, dispensers, nozzles, stoppers, adapters, cannulas, transfer devices, ampoules, backstops, anticoagulants, coagulation activators, hyaluronic acid and chitosan, intended for the preparation of platelet concentrate, platelet rich plasma, platelet poor plasma, fibrin gel, platelet rich fibrin, cell extracts, cell concentrates, stem cells, hyaluronic acid, chitosan or any combinations thereof; kits intended for tissue and cellular regeneration, rejuvenation, healing and repair comprised of receptacles, namely, medical syringes, medical tubes, vials, jars, bags, pouches, cartridges, bottles, cylinders or pods and needles for regenerative medicine, isolation and application of platelets and cells, for example from blood, fat, bone marrow, stem cells and other tissue, and kits comprising medical syringes, medical tubes and needles for regenerative medicine, the preparation of a platelet concentrate, the isolation and application of platelets and cells, for example from blood, fat, bone marrow, stem cells and other tissue; surgical apparatus and instruments for medical, dental or veterinary use; surgical and medical apparatus and instruments for use in dentistry, orthopedics, cosmetic surgery, aesthetic surgery, general surgery, ophthalmology and mesotherapy; surgical and medical apparatus and instruments for use in cardiovascular, aesthetic, cardiac, thoracic, transplantation, head and neck, oral, bone, cartilage, tendon, implant, gastrointestinal, orthopedic, neurosurgical, facial, face-lift and plastic surgery; centrifuges for medical use; suture material; medical syringes for injections; cases fitted for medical instruments; receptacles for applying medicines, namely, bottles, jars, containers, cannulae, syringes, tubes, infusion and injection devices for administering drugs, platelet-rich plasma, hyaluronic acid, and hydrogels; medical tubing for administering drugs, platelet-rich plasma, hyaluronic acid and hydrogels; syringes for medical use; cases fitted for use by surgeons or doctors; containers specially adapted for storing tissue and biological samples for medical purposes; non-metallic containers for transporting and storing organs, tissue and cells for medical purposes; medical injection instruments with and without needles; medical instruments, namely, surgical instruments for facilitating the identification, separation or removal of biological tissue for medical purposes; surgical and medical apparatus and instruments used in general surgery; medical apparatus used for taking blood; medical apparatus used for taking blood samples; apparatus used for separating blood components for medical purposes; medical instruments used for filtering blood and blood components for medical purposes; medical apparatus used for introducing pharmaceutical preparations into the human body; medical instruments, namely, surgical instruments for biological tissue; medical devices, namely, surgical instruments for biological tissues; medical apparatus intended for the preparation of platelet concentrate, glycosaminoglycan and polysaccharide hydrogels; such goods not including implantable medical devices for use in the regeneration of natural tissue

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Apr 7, 2026 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 7, 2026 ABN2
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Nov 24, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Nov 24, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 2, 2025 GNRN
NON-FINAL ACTION E-MAILED
Sep 2, 2025 GNRT
SU - NON-FINAL ACTION - WRITTEN
Sep 2, 2025 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Aug 8, 2025 SUPC
DIVISIONAL PROCESSING COMPLETE
Aug 8, 2025 DPCC
USE AMENDMENT FILED
Aug 1, 2025 IUAF
DIVISIONAL REQUEST RECEIVED
Aug 1, 2025 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Aug 1, 2025 ERTD
TEAS STATEMENT OF USE RECEIVED
Aug 1, 2025 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 18, 2025 EXRA
SOU EXTENSION 4 GRANTED
Jul 17, 2025 EX4G
SOU EXTENSION 4 FILED
Jul 17, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 17, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 22, 2025 EXRA
SOU EXTENSION 3 GRANTED
Jan 22, 2025 EX3G
SOU EXTENSION 3 FILED
Jan 21, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 21, 2025 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 5, 2024 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 5, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 5, 2024 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 24, 2024 EXRA
SOU EXTENSION 2 GRANTED
Jul 18, 2024 EX2G
SOU EXTENSION 2 FILED
Jul 18, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 18, 2024 EEXT
SOU EXTENSION 1 GRANTED
Jun 15, 2024 EX1G
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 14, 2024 EXRA
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 10, 2024 AITU
ASSIGNED TO EXAMINER
May 29, 2024 DOCK
NOTICE OF REVIVAL - E-MAILED
Feb 20, 2024 NREV
PETITION TO REVIVE-GRANTED
Feb 20, 2024 PETG
TEAS PETITION TO REVIVE RECEIVED
Feb 20, 2024 PROA
TEAS PETITION TO REVIVE RECEIVED
Feb 20, 2024 PROA
ABANDONMENT - NO USE STATEMENT FILED
Feb 19, 2024 ABN6
SOU EXTENSION 1 FILED
Jan 18, 2024 EXT1
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 18, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 23, 2023 NPUB
PUBLISHED FOR OPPOSITION
May 23, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 3, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 17, 2023 CNSA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 27, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 27, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 27, 2023 REAP
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 17, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 17, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 17, 2023 ERFR
ASSIGNED TO EXAMINER
Feb 21, 2023 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 20, 2022 TCCA
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Dec 20, 2022 EWOR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Dec 20, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 20, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 20, 2022 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 19, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 19, 2022 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Dec 19, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 19, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 19, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 19, 2022 COAR
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 19, 2022 GNFN
FINAL REFUSAL E-MAILED
Dec 19, 2022 GNFR
FINAL REFUSAL WRITTEN
Dec 19, 2022 CNFR
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 17, 2022 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 21, 2022 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 20, 2021 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 22, 2021 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 20, 2020 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 27, 2020 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 24, 2019 RCSC
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 21, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 21, 2019 REAP
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 24, 2019 RCSC
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 1, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 1, 2018 REAP
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 24, 2018 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 24, 2018 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 24, 2017 RCSC
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 5, 2017 ASGN
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 14, 2017 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 14, 2016 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 14, 2016 GNSL
SUSPENSION LETTER WRITTEN
Jul 14, 2016 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 24, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 24, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 24, 2016 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 2, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 2, 2016 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 9, 2016 GNRN
NON-FINAL ACTION E-MAILED
Jan 9, 2016 GNRT
NON-FINAL ACTION WRITTEN
Jan 9, 2016 CNRT
ASSIGNED TO EXAMINER
Jan 6, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 22, 2015 NWOS
NEW APPLICATION ENTERED
Sep 22, 2015 NWAP